These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 38548057

  • 1. Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center descriptive analysis.
    Harmacek D, Weidmann L, Castrezana Lopez K, Schmid N, Korach R, Bortel N, von Moos S, Rho E, Helmchen B, Gaspert A, Schachtner T.
    Am J Transplant; 2024 Sep; 24(9):1652-1663. PubMed ID: 38548057
    [Abstract] [Full Text] [Related]

  • 2. Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney Transplantation.
    Parajuli S, Redfield RR, Garg N, Aziz F, Mohamed M, Astor BC, Zhong W, Djamali A, Mandelbrot DA.
    Transplantation; 2019 Jul; 103(7):1468-1476. PubMed ID: 30335696
    [Abstract] [Full Text] [Related]

  • 3. T-cell Mediated Rejection Associated Microvascular Inflammation in the Allograft Kidney: RNAseq Analysis Using the Banff Human Organ Transplant Gene Panel.
    Barwad A, Huang Y, Randhawa P.
    Clin Transplant; 2024 Jul; 38(7):e15410. PubMed ID: 39033507
    [Abstract] [Full Text] [Related]

  • 4. Highly Sensitized Candidates Remain at Risk for Microvascular Inflammation Even When Donor-specific Antibody Is Avoided: A Matched Cohort Study.
    Agrawal A, Balakrishnan S, Gandhi MJ, Alexander MP, Cornell L, Bentall AJ, Kukla A, Stegall M, Schinstock CA.
    Transplantation; 2024 Sep 01; 108(9):1986-1993. PubMed ID: 38578704
    [Abstract] [Full Text] [Related]

  • 5. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
    Senev A, Coemans M, Lerut E, Van Sandt V, Daniëls L, Kuypers D, Sprangers B, Emonds MP, Naesens M.
    Am J Transplant; 2019 Mar 01; 19(3):763-780. PubMed ID: 30107078
    [Abstract] [Full Text] [Related]

  • 6. Donor-derived cell-free DNA predicted allograft rejection and severe microvascular inflammation in kidney transplant recipients.
    Kim HD, Bae H, Kang H, Lee H, Eum SH, Yang CW, Choi YJ, Chung BH, Oh EJ.
    Front Immunol; 2024 Mar 01; 15():1433918. PubMed ID: 39044817
    [Abstract] [Full Text] [Related]

  • 7. Isolated v-lesion in kidney transplant recipients: Characteristics, association with DSA, and histological follow-up.
    Rabant M, Boullenger F, Gnemmi V, Pellé G, Glowacki F, Hertig A, Brocheriou I, Suberbielle C, Taupin JL, Anglicheau D, Legendre C, Duong Van Huyen JP, Buob D.
    Am J Transplant; 2018 Apr 01; 18(4):972-981. PubMed ID: 29206350
    [Abstract] [Full Text] [Related]

  • 8. Molecular signatures and clinical outcomes of transplant glomerulopathy stratified by microvascular inflammation and donor-specific antibody.
    Lubetzky M, Hayde N, Ó Broin P, Ajaimy M, Bao Y, Mohammed O, Schwartz D, Pullman J, Akalin E.
    Clin Transplant; 2019 Mar 01; 33(3):e13469. PubMed ID: 30578675
    [Abstract] [Full Text] [Related]

  • 9. Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients.
    Wehmeier C, Hönger G, Cun H, Amico P, Hirt-Minkowski P, Georgalis A, Hopfer H, Dickenmann M, Steiger J, Schaub S.
    Am J Transplant; 2017 Aug 01; 17(8):2092-2102. PubMed ID: 28245084
    [Abstract] [Full Text] [Related]

  • 10. Identifying Subphenotypes of Antibody-Mediated Rejection in Kidney Transplants.
    Halloran PF, Merino Lopez M, Barreto Pereira A.
    Am J Transplant; 2016 Mar 01; 16(3):908-20. PubMed ID: 26743766
    [Abstract] [Full Text] [Related]

  • 11. A Probabilistic Approach to Histologic Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies.
    Halloran PF, Famulski KS, Chang J.
    Am J Transplant; 2017 Jan 01; 17(1):129-139. PubMed ID: 27340822
    [Abstract] [Full Text] [Related]

  • 12. The Value of Protocol Biopsies to Identify Patients With De Novo Donor-Specific Antibody at High Risk for Allograft Loss.
    Schinstock CA, Cosio F, Cheungpasitporn W, Dadhania DM, Everly MJ, Samaniego-Picota MD, Cornell L, Stegall MD.
    Am J Transplant; 2017 Jun 01; 17(6):1574-1584. PubMed ID: 27977905
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.
    Orandi BJ, Alachkar N, Kraus ES, Naqvi F, Lonze BE, Lees L, Van Arendonk KJ, Wickliffe C, Bagnasco SM, Zachary AA, Segev DL, Montgomery RA.
    Am J Transplant; 2016 Jan 01; 16(1):213-20. PubMed ID: 26317487
    [Abstract] [Full Text] [Related]

  • 17. Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies.
    Gupta A, Broin PÓ, Bao Y, Pullman J, Kamal L, Ajaimy M, Lubetzky M, Colovai A, Schwartz D, de Boccardo G, Golden A, Akalin E.
    Kidney Int; 2016 Jan 01; 89(1):217-25. PubMed ID: 26422506
    [Abstract] [Full Text] [Related]

  • 18. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 01; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 19. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J, Xue W, Qing X, Jing X, Hou J, Tian X, Guo Q, He X, Cai J.
    Clin Transpl; 2014 Oct 01; ():223-30. PubMed ID: 26281149
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.